Cardiovascular disease

Susanna M. Hamilton, Ó³»­´«Ã½ Communications

The study of structural variation — large-scale changes in DNA that can, in some cases, refashion entire chromosomes — in the genomic era has lagged behind that of sequence variation. But there’s a growing appreciation of how important structural variants are to human biology and disease. What makes these variants more challenging to study, and what is being done to overcome those challenges?

Ó³»­´«Ã½-led team reveals new genetic findings that link major pathway for triglyceride metabolism to risk of coronary artery disease

For decades, scientists have searched for the biological roots of coronary artery disease (CAD), the most common form of heart disease and the leading cause of death in the United States. LDL, a type of fat in the blood, emerged early on as a key player — high levels raise the risk of CAD and heart attack. Based on these insights, LDL-lowering drugs were first introduced in the late 1980’s and are now a staple of modern medicine.